Recent 13F filings as of December 2025 show that 145 institutional investors hold a position in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 5,653,211 | 1,090,000 | 23.89% | $42,399,083.00 |
| JANUS HENDERSON GROUP PLC | 31 Dec, 2025 | 4,635,875 | 2,882,508 | 164.40% | $34,726,165.00 |
| BVF INC/IL | 31 Dec, 2025 | 4,629,289 | 0 | 0.00% | $34,719,668.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 4,302,905 | 174,489 | 4.23% | $32,271,789.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,064,876 | 195,746 | 5.06% | $30,486,573.00 |
| Novo Holdings A/S | 31 Dec, 2025 | 3,650,737 | 1,650,737 | 82.54% | $27,380,528.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,093,527 | 518,405 | 20.13% | $23,201,453.00 |
| STATE STREET CORP | 31 Dec, 2025 | 2,688,880 | 1,785,106 | 197.52% | $20,166,600.00 |
| ARMISTICE CAPITAL, LLC | 31 Dec, 2025 | 1,936,000 | 840,000 | 76.64% | $14,520,000.00 |
| FEDERATED HERMES, INC. | 31 Dec, 2025 | 1,609,482 | 14,650 | 0.92% | $12,071,116.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 1,539,860 | 1,539,860 | 0.00% | $11,548,950.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 1,235,156 | 1,060,156 | 605.80% | $9,263,670.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,012,025 | 98,506 | 10.78% | $7,591,665.00 |
| Evergreen Quality Fund GP, Ltd. | 31 Dec, 2025 | 951,474 | 951,474 | 0.00% | $7,136,055.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 832,591 | 13,325 | 1.63% | $6,244,433.00 |
| DEUTSCHE BANK AG\ | 31 Dec, 2025 | 704,207 | 160,876 | 29.61% | $5,281,553.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 672,695 | -163,216 | -19.53% | $5,045,215.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 512,900 | 199,714 | 63.77% | $3,846,750.00 |
| ArrowMark Colorado Holdings LLC | 31 Dec, 2025 | 485,389 | -18,726 | -3.71% | $3,640,418.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 475,737 | 475,737 | 0.00% | $3,568,028.00 |